Workflow
2 Stocks From Top Growth Sectors to Buy in August for the Rest of 2026
ZACKS· 2026-07-31 04:01
Key Takeaways Technology stands out as the first sector to watch. July's weakness reflected concerns over AI capital spending and valuations rather than deteriorating demand. Enterprise adoption of generative AI continues to accelerate, with cloud providers, semiconductor companies, networking vendors and software firms benefiting from expanding AI workloads. Continued investment in AI infrastructure by hyperscalers, despite near-term investor scrutiny, reinforces the sector's long-term growth outlook. Amon ...
Micron & 2 Profitable Stocks to Buy Before August for Big Upside
ZACKS· 2026-07-31 04:01
Key Takeaways Micron, NVIDIA and TD SYNNEX passed profitability screens with strong net income ratios. MU pairs a 55.9% net profit margin with projected earnings growth of 791% this year. NVIDIA and SNX combine solid profitability with strong earnings growth expectations.With August, a relatively volatile month for the stock market, approaching, investors should focus on companies that generate consistently strong returns after covering both operating and non-operating expenses. These companies are generall ...
STANDEX REPORTS FISCAL FOURTH QUARTER AND FISCAL YEAR 2026 FINANCIAL RESULTS
Prnewswire· 2026-07-31 04:01
STANDEX REPORTS FISCAL FOURTH QUARTER AND FISCAL YEAR 2026 FINANCIAL RESULTS Accessibility Statement Skip Navigation SALEM, N.H., July 30, 2026 /PRNewswire/ -- Standex International Corporation(NYSE: SXI) today reported financial results for the fourth quarter of fiscal year 2026 ended June 30, 2026. Summary Financial Results - Total | ($M except EPS and Dividends) | 4Q26 | 4Q25 | 3Q26 | Y/Y | Q/Q | | --- | --- | --- | --- | --- | --- | | Net Sales | $228.3 | $222.0 | $224.6 | 2.8 % | 1.6 % | | Operating In ...
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Prnewswire· 2026-07-31 04:01
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results Accessibility Statement Skip Navigation – Robust Q2 performance with total revenue of $361 million, including $239 million of product revenue – – Full-year 2026 expected total revenue increased to $1.18 to $1.28 billion, with full-year product revenue guidance raised to $850 to $950 million – – Sephience™ (sepiapterin) Q2 2026 revenue of $151 million, with continued broad uptake and geographical expansion – – Strong ...
Atlanticus to Host Second Quarter 2026 Earnings Call and Webcast on August 6, 2026, at 5:00 p.m. ET
Globenewswire· 2026-07-31 04:01
ATLANTA, July 30, 2026 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” the “Company,” “we,” “our” or “us”), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced that it will host a conference call and live webcast to discuss its second quarter financial results and operating performance on Thursday, August 6, 2026 at 5:00 p.m. Eastern Time. The live ...
Asure Announces Second Quarter 2026 Results
Globenewswire· 2026-07-31 04:01
Second Quarter 2026 Revenues of $37.1 Million up 23% year over year Recurring Revenue of $34.0 Million up 19% year over year AUSTIN, Texas, July 30, 2026 (GLOBE NEWSWIRE) -- Asure Software, Inc. (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management software solutions, today reported results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights* Revenue of $37.1 million, up 23% from $30.1 millionRecurring revenue of $34.0 million, up 19% from $28.6 million ...
Neurocrine Biosciences Reports Second-Quarter 2026 Financial Results
Prnewswire· 2026-07-31 04:01
Total Second-Quarter 2026 Revenue Grew 39% Year-Over-Year to $959 Million INGREZZA ® (valbenazine) 2026 Net Sales Guidance Raised to $2.825 to $2.875 Billion Acquisition of Soleno Therapeutics Completed in May 2026 SAN DIEGO, July 30, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the second quarter ended June 30, 2026. "Our second quarter performance demonstrates the power of a strategy designed to compound over time," said Kyle W. ...
GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference
Prnewswire· 2026-07-31 04:01
GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference Accessibility Statement Skip Navigation 21% more press release views with Request a Demo Also from this source GRAIL to Announce Second Quarter 2026 Financial Results MENLO PARK, Calif., July 30, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity 46th Annual Growth Conference in B ...
InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing
Globenewswire· 2026-07-31 04:01
Ms. Kennedy returns to InspireMD having previously served as Sales Director supporting the initial U.S. launch of CGuard PrimeMIAMI, July 30, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of accomplished commercial leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing, reporting to CEO Marvin Slosman. Ms. Kennedy brings more than ...
Kish Bancorp, Inc. Names Tina M. Collins Chief Financial Officer, Strengthens Finance Team with Key Leadership Additions
Globenewswire· 2026-07-31 04:01
Tina Collins CFO, Kish Bancorp, Inc. Sean Rainey Controller, Kish Bancorp, Inc. STATE COLLEGE, Pa., July 30, 2026 (GLOBE NEWSWIRE) -- Kish Bancorp, Inc. (OTCQX: KISB) (“Kish” or the “Company”), parent company of Kish Bank, today announced that Tina M. Collins has been appointed Chief Financial Officer (CFO) of Kish Bancorp and Kish Bank, effective immediately. Collins most recently served as interim CFO since October 2025 and steps into the permanent role following a public recruiting search that dr ...